Ulrich B. Keller, et.al., Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis., The EMBO journal, 2007, 26

http://rdf.ncbi.nlm.nih.gov/pubmed/17464290

Ulrich B. Keller, et.al., Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis., The EMBO journal, 2007, 26

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD02548
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD02548

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased lymphocyte cell number_Cks1b<tm1Sir>/Cks1b<tm1Sir>,Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0005016IC57BLC57BL6SJLCks1btm1SirCks1btm1SirTgIghMyc22BriTgIghMyc22BriCks1btm1Sir
• decreased metastatic potential_Cks1b<tm1Sir>/Cks1b<tm1Sir>,Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0001273IC57BLC57BL6SJLCks1btm1SirCks1btm1SirTgIghMyc22BriTgIghMyc22BriCks1btm1Sir
• premature death_Cks1b<tm1Sir>/Cks1b<tm1Sir>,Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0002083IC57BLC57BL6SJLCks1btm1SirCks1btm1SirTgIghMyc22BriTgIghMyc22BriCks1btm1Sir
• decreased spleen weight_Cks1b<tm1Sir>/Cks1b<tm1Sir>,Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0004953IC57BLC57BL6SJLCks1btm1SirCks1btm1SirTgIghMyc22BriTgIghMyc22BriCks1btm1Sir
• enlarged spleen_Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0000691IC57BLC57BL6SJLTgIghMyc22BriTgIghMyc22Bri
• increased lymphoma incidence_Cks1b<tm1Sir>/Cks1b<tm1Sir>,Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0012431IC57BLC57BL6SJLCks1btm1SirCks1btm1SirTgIghMyc22BriTgIghMyc22BriCks1btm1Sir
• premature death_Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0002083IC57BLC57BL6SJLTgIghMyc22BriTgIghMyc22Bri
• increased lymphocyte cell number_Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0005013IC57BLC57BL6SJLTgIghMyc22BriTgIghMyc22Bri
• increased lymphoma incidence_Cks1b<tm1Sir>/Cks1b<+>,Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0012431IC57BLC57BL6SJLCks1btm1SirCks1bTgIghMyc22BriCks1btm1SirTgIghMyc22BriCks1b
• decreased B cell proliferation_Cks1b<tm1Sir>/Cks1b<tm1Sir>,Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0005093IC57BLC57BL6SJLCks1btm1SirCks1btm1SirTgIghMyc22BriTgIghMyc22BriCks1btm1Sir
• decreased leukocyte cell number_Cks1b<tm1Sir>/Cks1b<tm1Sir>,Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0000221IC57BLC57BL6SJLCks1btm1SirCks1btm1SirTgIghMyc22BriTgIghMyc22BriCks1btm1Sir
• premature death_Cks1b<tm1Sir>/Cks1b<+>,Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0002083IC57BLC57BL6SJLCks1btm1SirCks1bTgIghMyc22BriCks1btm1SirTgIghMyc22BriCks1b
• increased metastatic potential_Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0001272IC57BLC57BL6SJLTgIghMyc22BriTgIghMyc22Bri
• increased lymphoma incidence_Tg(IghMyc)22Bri/?
  http://metadb.riken.jp/0012431IC57BLC57BL6SJLTgIghMyc22BriTgIghMyc22Bri